E

electroCore
D

ECOR

11.510
USD
0.06
(0.52%)
Market Open
Volume
163
EPS
-2
Div Yield
-
P/E
-7
Market Cap
75,443,342
Related Instruments
    E
    EVOK
    0.06000
    (1.36%)
    4.46000 USD
    I
    IPHA
    -0.18000
    (-10.71%)
    1.50000 USD
    O
    ORGO
    -0.14500
    (-3.63%)
    3.85500 USD
    P
    PLX
    -0.02000
    (-1.42%)
    1.39000 USD
    P
    PTE
    -0.01510
    (-2.08%)
    0.67000 USD
    S
    SNDL
    0.00500
    (0.26%)
    1.95500 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: electroCore

Sector: Healthcare
Industry: Medical Devices
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated withmigraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.